The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trop-2: A promising new therapeutic target in penile squamous cell carcinoma.
 
Richard Weiten
Employment - University Hospital Bonn
 
Carolina Kessler
No Relationships to Disclose
 
Hanna Elisa Spohn
No Relationships to Disclose
 
Enno Storz
Employment - University Hospital Cologne
 
David A. Pfister
Employment - University Hospital Cologne
 
Tim Nestler
Employment - Federal Armed Services Hospital Koblenz
Honoraria - Janssen
 
Yuri Tolkach
Employment - University Hospital Cologne
Patents, Royalties, Other Intellectual Property - Indica Lab
 
Ralph M. Wirtz
Employment - STRATIFYER Molecular Pathology
Leadership - STRATIFYER Molecular Pathology
Stock and Other Ownership Interests - STRATIFYER Molecular Pathology
Consulting or Advisory Role - BioNTech Diagnostics (Inst); Janssen Oncology (Inst)
Research Funding - Janssen Research & Development (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from BioNTech (Inst); Royalties from Qiagen (Inst)
 
Melanie von Brandenstein
Employment - University of Cologne
 
Philipp Krausewitz
Employment - University Hospital Bonn
Honoraria - Bayer; Janssen-Cilag; Medac
Travel, Accommodations, Expenses - Bayer; Janssen-Cilag; Medac
 
Axel Heidenreich
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS Global; Clovis Oncology; Janssen-Cilag; MSD Oncology
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Ipsen; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Astellas Pharma; Bayer; BMS Oncology; Sanofi